Simplex Trading’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Simplex Trading’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	–	–	10084
2023 Q3	$0	Buy	4 +2	+100%	+$102	﹤0.01%	10102
2023 Q2	$0	Sell	2 -282	-99%	-$23.5K	﹤0.01%	10184
2023 Q1	$23K	Sell	284 -26	-8%	-$2.86K	﹤0.01%	6797
2022 Q4	$42K	Sell	310 -7	-2%	-$868	﹤0.01%	6094
2022 Q3	$32K	Buy	317 +104	+49%	+$20.4K	﹤0.01%	7004
2022 Q2	$48K	Buy	+213	New	+$54.4K	﹤0.01%	6566
2022 Q1	–	Sell	-27	Closed	-$7.46K	–	11606
2021 Q4	$5K	Buy	27 +16	+145%	+$5.77K	﹤0.01%	9592
2021 Q3	$6K	Hold	11	–	–	﹤0.01%	9241
2021 Q2	$6K	Buy	+11	New	+$5.82K	﹤0.01%	9418
2021 Q1	–	Sell	-6	Closed	-$3.86K	–	10274
2020 Q4	$2K	Sell	6 -83	-93%	-$34.7K	﹤0.01%	8030
2020 Q3	$33K	Buy	+89	New	+$97K	﹤0.01%	5997

Other funds holding VCNX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's VCNX Position: Q4 2023 in Review

Simplex Trading sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2023, closing a stake of 4 shares.

Simplex Trading first reported a position in VCNX in Q3 2020 and held it in 11 quarters. The position peaked at $48K in Q2 2022. 17 funds tracked by Wall St. Rank hold VCNX as of Q4 2023.

Simplex Trading reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Simplex Trading sold 4 Vaccinex, Inc. Common Stock shares in Q4 2023.
Simplex Trading first reported a position in Vaccinex, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
Simplex Trading's Vaccinex, Inc. Common Stock position peaked at $48K in Q2 2022.
17 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.